Page 6 - Annual Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Do Reata Pharmaceuticals Inc (RETA) beta value of 1 16 signposts another twist?

Do Reata Pharmaceuticals Inc (RETA) beta value of 1 16 signposts another twist?
investchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investchronicle.com Daily Mail and Mail on Sunday newspapers.

United statesReata pharmaceuticals incReata pharmaceuticals announces participationReata pharmaceuticalsAnnual biopharmaAnnual biopharma conferenceWall streetEquity ratioRaw stochastic

Ardelyx to Participate in Upcoming Investor Conferences

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative.

New yorkUnited statesFosun pharmaPrnewswire ardelyx incLadenburg thalmannArdelyx incAnnual biopharmaAnnual global investmentNew york cityKyowa kirinKnight therapeutics

Immunic, Inc to Participate in Investor Conferences in September

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused.

United statesEdna kaplanPaula schwartzJessica breuDaniel vittExchange commissionRx communications groupWells fargoImmunic incAnnual biopharmaChief executive officerInvestor relationsAnnual biopharma conferenceThalmann healthcareThalmann healthcare conferenceNew york

Eiger BioPharmaceuticals to Participate in Three Upcoming Investor Conferences

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies.

New yorkUnited statesSylvia wheelerSarah mathiesonEiger biopharmaceuticals incCorporate affairsEiger biopharmaceuticalsAnnual biopharmaAnnual global investment

NuCana plc: NuCana to Participate in Citi s 17th Annual BioPharma Conference

EDINBURGH, United Kingdom, Aug. 31, 2022 (GLOBE NEWSWIRE) NuCana plc (NASDAQ: NCNA) announced today that management will host one-on-one meetings at Citi's 17th Annual BioPharma Conference. Event:

United statesUnited kingdomCity ofHughs griffithMarion janicChris brinzeyExchange commissionCompany annual report on formAnnual biopharmaPrivate securities litigation reform actAnnual report